These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 17473574

  • 1. Platelet function in clopidogrel-treated patients with acute coronary syndrome.
    Sibbing D, von Beckerath O, Schömig A, Kastrati A, von Beckerath N.
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):335-9. PubMed ID: 17473574
    [Abstract] [Full Text] [Related]

  • 2. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
    Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, Bray PF, Kleiman NS.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):27-33. PubMed ID: 16386660
    [Abstract] [Full Text] [Related]

  • 3. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome.
    Xiao Z, Théroux P.
    J Am Coll Cardiol; 2004 Jun 02; 43(11):1982-8. PubMed ID: 15172401
    [Abstract] [Full Text] [Related]

  • 4. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV, Papathanasiou AI, Elisaf M, Goudevenos JA, Tselepis AD.
    Platelets; 2005 Aug 02; 16(5):287-92. PubMed ID: 16011979
    [Abstract] [Full Text] [Related]

  • 5. Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting.
    Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Barrera-Ramirez C, Sabaté M, Hernández R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Costa MA, Bass TA, Macaya C.
    Thromb Res; 2005 Aug 02; 115(1-2):101-8. PubMed ID: 15567460
    [Abstract] [Full Text] [Related]

  • 6. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL, Malinin AI, Jerome SD, Lowry DR, Morgan AW, Sane DC, Tanguay JF, Steinhubl SR, O'connor CM.
    Am Heart J; 2003 Oct 02; 146(4):713-20. PubMed ID: 14564328
    [Abstract] [Full Text] [Related]

  • 7. Is a 300 mg clopidogrel loading dose sufficient to inhibit platelet function early after coronary stenting? A platelet function profile study.
    Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Hernández-Antolín R, Moreno R, Escaned J, Alfonso F, Bañuelos C, Macaya C.
    J Invasive Cardiol; 2004 Jun 02; 16(6):325-9. PubMed ID: 15156004
    [Abstract] [Full Text] [Related]

  • 8. Lack of association between the 807 C/T polymorphism of glycoprotein Ia gene and post-treatment platelet reactivity after aspirin and clopidogrel in patients with acute coronary syndrome.
    Cuisset T, Frere C, Quilici J, Morange PE, Saut N, Romero-Barra M, Camoin L, Lambert M, Juhan-Vague I, Bonnet JL, Alessi MC.
    Thromb Haemost; 2007 Feb 02; 97(2):212-7. PubMed ID: 17264949
    [Abstract] [Full Text] [Related]

  • 9. Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting.
    Cuisset T, Frere C, Quilici J, Morange PE, Nait-Saidi L, Carvajal J, Lehmann A, Lambert M, Bonnet JL, Alessi MC.
    J Am Coll Cardiol; 2006 Oct 03; 48(7):1339-45. PubMed ID: 17010792
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of reloading to overcome clopidogrel nonresponsiveness in patients with acute myocardial infarction.
    Matetzky S, Fefer P, Shenkman B, Varon D, Savion N, Hod H.
    Am J Cardiol; 2008 Sep 01; 102(5):524-9. PubMed ID: 18721506
    [Abstract] [Full Text] [Related]

  • 11. Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention.
    Hochholzer W, Trenk D, Frundi D, Blanke P, Fischer B, Andris K, Bestehorn HP, Büttner HJ, Neumann FJ.
    Circulation; 2005 May 24; 111(20):2560-4. PubMed ID: 15809367
    [Abstract] [Full Text] [Related]

  • 12. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention.
    Quinn MJ, Bhatt DL, Zidar F, Vivekananthan D, Chew DP, Ellis SG, Plow E, Topol EJ.
    Am J Cardiol; 2004 Mar 15; 93(6):679-84. PubMed ID: 15019868
    [Abstract] [Full Text] [Related]

  • 13. Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy.
    Kastrati A, von Beckerath N, Joost A, Pogatsa-Murray G, Gorchakova O, Schömig A.
    Circulation; 2004 Oct 05; 110(14):1916-9. PubMed ID: 15262828
    [Abstract] [Full Text] [Related]

  • 14. Effects of platelet and inflammatory system activation on outcomes in diabetic patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kuliczkowski W, Greif M, Gąsior M, Kaczmarski J, Pres D, Poloński L.
    Kardiol Pol; 2011 Oct 05; 69(6):531-7. PubMed ID: 21678284
    [Abstract] [Full Text] [Related]

  • 15. Anti-thrombotic action of clopidogrel and P1(A1/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin.
    Dropinski J, Musial J, Jakiela B, Wegrzyn W, Sanak M, Szczeklik A.
    Thromb Haemost; 2005 Dec 05; 94(6):1300-5. PubMed ID: 16411409
    [Abstract] [Full Text] [Related]

  • 16. Role of the T744C polymorphism of the P2Y12 gene on platelet response to a 600-mg loading dose of clopidogrel in 597 patients with non-ST-segment elevation acute coronary syndrome.
    Cuisset T, Frere C, Quilici J, Morange PE, Saut N, Lambert M, Camoin L, Vague IJ, Bonnet JL, Alessi MC.
    Thromb Res; 2007 Dec 05; 120(6):893-9. PubMed ID: 17337040
    [Abstract] [Full Text] [Related]

  • 17. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial.
    Yong G, Rankin J, Ferguson L, Thom J, French J, Brieger D, Chew DP, Dick R, Eccleston D, Hockings B, Walters D, Whelan A, Eikelboom JW.
    Am Heart J; 2009 Jan 05; 157(1):60.e1-9. PubMed ID: 19081397
    [Abstract] [Full Text] [Related]

  • 18. Relationships between optical aggregometry (type born) and flow cytometry in evaluating ADP-induced platelet activation.
    Sbrana S, Della Pina F, Rizza A, Buffa M, De Filippis R, Gianetti J, Clerico A.
    Cytometry B Clin Cytom; 2008 Jan 05; 74(1):30-9. PubMed ID: 17630652
    [Abstract] [Full Text] [Related]

  • 19. High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability.
    Angiolillo DJ, Fernández-Ortiz A, Bernardo E, Ramírez C, Sabaté M, Bañuelos C, Hernández-Antolín R, Escaned J, Moreno R, Alfonso F, Macaya C.
    Eur Heart J; 2004 Nov 05; 25(21):1903-10. PubMed ID: 15522469
    [Abstract] [Full Text] [Related]

  • 20. Whole blood aggregometry for evaluation of the antiplatelet effects of clopidogrel.
    Hochholzer W, Trenk D, Frundi D, Neumann FJ.
    Thromb Res; 2007 Nov 05; 119(3):285-91. PubMed ID: 16603231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.